Dec 3, 2020
Our Dog of the Week is Sona Nanotech Inc. (SONA:CSE), a Life Sciences company with the goal of developing and producing its own lateral flow rapid COVID-19 antigen tests. The stock, a market darling earlier in the year, is down over 92% from its highs, and 62% this week alone. We reviewed it earlier in the year in the $2.00-$2.50 range and with zero sales and only a small chance of actually selling its test kits in a tight time frame, we saw no serious investment merit long-term in the stock. With Sona cut in half, we take a look at the business once again.
Dog of the Week Sona Nanotech Inc. (SONA:CSE)
Book a Call Here
Click here to book a complimentary 10-minute call with Ryan, Aaron, Brennan, or one of our staff and see what services may be right for you.